226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.
Poster Session: Antimicrobial Novel Agents
Anthony Pfaffle, MD
Head of Patient Advocacy and Special Projects
CorMedix Inc.
Berkeley Heights, New Jersey, United States
Leonard R. Duncan, PhD (he/him/his)
Associate Director
JMI Laboratories
North Liberty, IA, United States
Mariana Castanheira, PhD
Chief Scientific Officer
JMI Laboratories/Element Materials
North Liberty, Iowa, United States
Bruce Reidenberg, MD, FAAP, FCP
Pharmaceutical Consultant
Independent (on behalf of CorMedix)
New York City, New York, United States
Cecilia G. Carvalhaes, MD, PhD (she/her/hers)
Associate Director for Clinical Microbiology
JMI Laboratories
North Liberty, IA, United States
Jessica Vaughn, JD, PhD
Attorney
Wiley Rein LLP (formerly Cormedix Inc. May 2019-Jan 2022)
Washington DC, District of Columbia, United States
Phoebe Mounts, JD
Executive VP and General Counsel
CorMedix Inc.
Berkeley Heights, New Jersey, United States